UK regulator recommends new safety measures for medicines containing pseudoephedrine Safety information for all medicines containing pseudoephedrine will be updated to make clear the risk of rare, but serious, side effects.…
Codeine linctus to be reclassified as a prescription-only medicine While codeine linctus is effective for long-term dry cough, the Medicines and Healthcare products Regulatory Agency said “misuse and abuse can have major health consequences”.…
MHRA says fluoroquinolones should be administered only when no other antibiotics are appropriate The Medicines and Healthcare products Regulatory Agency has issued new restrictions on fluoroquinolone use, following reports of serious adverse reactions in patients.…
Medicines regulator seeks expert advice on risk of developmental disorders in children fathered by men on valproate The Medicines and Healthcare products Regulatory Agency is to look again at evidence from a study evaluating the link between paternal valproate exposure and developmental disorders in children.…
Patient hospitalised owing to incorrect dosing advice when switching insulin products A national patient safety alert said patients had been incorrectly advised on the number of units to administer from Tresiba pre-filled insulin injection pens.…
Smoking cessation medicine cytisine to be available in January 2024, distributor confirms Cytisine was approved for use in the UK by the Medicines and Healthcare products Regulatory Agency in March 2019, but no supplies have been previously available.…
Coroner advises NHS England to warn prescribers about interaction of tramadol and warfarin The coroner’s report says NHS England’s response “must contain details of action taken or proposed to be taken, setting out the timetable for action” or must explain why no action is proposed.…
Immunocompromised patients at risk from contaminated eye gels, UKHSA warns Patients who are immunocompromised should not be treated with carbomer-containing lubricating eye products owing to contamination, the UK Health Security Agency has said.…
New valproate prescriptions must be signed off by two specialist doctors from January 2024, says MHRA The requirement for valproate prescriptions, which will come into effect on 31 January 2024, was first announced in December 2022.…
Safety measures introduced for isotretinoin prescribing in patients aged under 18 years Recommendations to improve the safety of prescribing the acne drug isotretinoin have been made by the Commission on Human Medicines.…